Astellas Pharma Inc. (TYO:4503)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical	2.14T	1.91T	1.60T	1.52T	1.30T
Pharmaceutical Growth	11.87%	19.25%	5.60%	17.16%	3.73%
Total	2.14T	1.91T	1.60T	1.52T	1.30T
Total Growth	11.87%	19.25%	5.60%	17.16%	3.73%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
USA	945.72B	871.90B	668.55B	658.25B	544.10B
USA Growth	8.47%	30.42%	1.57%	20.98%	13.65%
Japan	317.06B	280.11B	286.22B	284.84B	268.94B
Japan Growth	13.19%	-2.14%	0.48%	5.91%	-9.52%
Others	876.47B	760.31B	648.90B	575.53B	483.12B
Others Growth	15.28%	17.17%	12.75%	19.13%	2.03%
Total	2.14T	1.91T	1.60T	1.52T	1.30T
Total Growth	11.87%	19.25%	5.60%	17.16%	3.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error